NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/05/2022
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Quick snapshot
MYLUNG CONSORTIUM
ST13
US500000090508673Class
Filing
Registration
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Case type
Recorded events
Latest update
Classification
Trademark type
Nice classes
Filing date
Registration date
Expiration date
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Structured fields from the responsible authority and the official record.
Status date
Last transaction
Responsible office
Status code
Official register
Filing basis
First use anywhere
First use in commerce
Drawing code
Owner type
Owner location
Examiner
Law office
Current location
Holders
Representatives
Auma N. Reggy MCKESSON CORPORATION
Nice Classes
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable electronic educational and professional publications, namely, newsletters, fact sheets, and brochures featuring information on research, testing, diagnosis, and treatment for lung cancer
Class 35
Business management, business administration, and office function services in the nature of the facilitation and management of the collection, tracking, and maintenance of data relating to the testing, diagnosis, and treatment of lung cancer from medical providers, patients, medical researchers, and medical, biopharmaceutical, and biotechnology companies; business administration and office function services in the nature of the coordinating the collection, compilation, tracking, and maintenance of information and data relating to the testing, diagnosis, and treatment of lung cancer; Market intelligence services, namely, providing therapeutic insights and benchmarking information to stakeholders in the fields of medicine and healthcare; Promoting collaboration within the medical, research, scientific, and pharmaceutical, biopharmaceutical and biotechnology communities to achieve advances in lung cancer testing, diagnosis, and treatment; Promoting the exchange of information within the medical, research, scientific, and pharmaceutical, biopharmaceutical and biotechnology communities to achieve advances in lung cancer testing, diagnosis, and treatment; Providing information for the development of best practices for the testing, diagnosis, and treatment of lung cancer
Class 42
Research services, namely, organizing collaborative research and development of protocols regarding the testing, diagnosis, and treatment of lung cancer for medical research purposes; Organizing collaboration in medical research and data collection around the testing, diagnosis, and treatment of lung cancer for medical research purposes; Organizing genomic, medical, biomedical and health care related research regarding lung cancer for medical research purposes; Providing medical research information in the field of lung cancer; Providing medical and scientific research information in the field of lung cancer
Class 44
Healthcare services, namely, collection of data and information on research, testing, diagnosis, and treatment of lung cancer for treatment and diagnostic purposes; Providing medical informational services for the purpose of raising awareness, and disseminating best practices for the testing, diagnosis, and treatment of lung cancer
History of USPTO decisions and trademark events.
26 publications found
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/05/2022
REGISTERED-PRINCIPAL REGISTER
07/05/2022
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/19/2022
PUBLISHED FOR OPPOSITION
04/19/2022
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/30/2022
APPROVED FOR PUB - PRINCIPAL REGISTER
03/12/2022
TEAS/EMAIL CORRESPONDENCE ENTERED
01/29/2022
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/28/2022
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/28/2022
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
10/06/2021
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/05/2021
NON-FINAL ACTION E-MAILED
10/05/2021
NON-FINAL ACTION WRITTEN
10/05/2021
USE AMENDMENT ACCEPTED
10/05/2021
AMENDMENT TO USE PROCESSING COMPLETE
08/16/2021
USE AMENDMENT FILED
08/16/2021
TEAS AMENDMENT OF USE RECEIVED
08/15/2021
TEAS/EMAIL CORRESPONDENCE ENTERED
08/12/2021
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/12/2021
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/12/2021
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/19/2021
NON-FINAL ACTION E-MAILED
05/19/2021
NON-FINAL ACTION WRITTEN
05/19/2021
ASSIGNED TO EXAMINER
05/14/2021
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/07/2021
NEW APPLICATION ENTERED
02/06/2021
Continuous trademark protection
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.